地址:广东省广州市天河区黄埔大道西601号暨南大学成教楼七楼
邮编:510632
电话:020-85220627
邮箱:chenjun@jnu.edu.cn
一、教育及研究经历
2018.10-至今 暨南大学 病原微生物研究院广东省病毒学重点实验室分子病毒学方向 副研究员
2014.7-2018.9 国家分子医学转化科学中心 肿瘤生物学国家重点实验室
肿瘤病毒学方向 博士后和助理研究员
导师:陈志南 中国工程院院士
2009.9-2014.6 武汉大学 生命科学学院 病毒学专业 博士
导师:刘奋勇 教授(加州大学伯克利分校传染病系终身教授)
二、研究和学术简介
主要从事(1)病毒与宿主的相互作用及其生物学意义,(2)DNA 病毒基因组复制及其调控机制,(3)疱疹病毒潜伏感染的维持调节机制,(4)肿瘤相关病毒免疫微环境的研究,以及(5)抗病毒创新药物研发。目前已成功主持并承担国家自然基金青年基金和中国博士后面上资助等科研项目,参与国家自然科学基金委国际(地区)合作与交流项目、国家自然基金重点项目和“973”计划等多项国家级科研项目的研究,并担任国家自然基金委青年项目评审专家。在本领域国际权威学术期刊PLoS pathogens、Journal of Virology、Virulence、Frontier in Microbiology、Viruses-basel、Molecular Microbiology、Virus Research、Autophagy、RNA等SCI期刊上发表13余篇研究论文,并申请国家专利2项。
三、主持及参与项目
1、CD147在HCMV感染入侵人胚脑神经细胞及导致神经中枢系统损伤中的作用机制研究:青年科学基金项目,编号31500137,总经费21.54万,2016.01-2018.12(主持);
2、CD147在HCMV感染入侵及原癌调控中的作用机制研究:中国博士后科学基金面上资助,编号2015M582847 (主持);
3、治疗乙型肝炎病毒感染的细菌类药物:国际(地区)合作与交流项目,编号81261120416,总经费30万,2013.01- 2013.12(参与);
4、人巨细胞病毒复制必需蛋白与宿主细胞因子相互作用的生物学效应:国家自然基金重点项目,编号81030031,总经费200万,2011.01-2014.12(参与);
5、病毒潜伏感染的分子机制:973计划,编号2011CB504800,总经费1700万,2011.1-2015.8(参与)。
四、论文发表
[1] Mengqiong Xu#, Sisi Xia#, Mei Wang, Xiaolian Liu, Xin Li, Weijie Chen, Yaohao Wang, Hongjian Li*, Chuan Xia*, Jun Chen* and Jianguo Wu*. Enzymatic independent role of Sphingosine kinase 2 in regulating the expression of type Ⅰ interferon during influenza A virus infection. PLOS Pathogens 2022, 18(9): e1010794.
[2] Shuyan Lai#, Mengqiong Xu#, Yaohao Wang, Ruilin Li, Chuan Xia, Sisi Xia* & Jun Chen*. Site-specific SUMOylation of viral polymerase processivity factor: a way of localizing to ND10 subnuclear domains for restricted and self-controlled reproduction of herpesvirus. Virulence. 2021, 12(1): p. 2883-2901.
[3] Jun Chen, Guanlie Li, Haiqing He, Xin Li, Wenjing Niu, Di Cao and Ao Shen*. Sumoylation of the Carboxy-Terminal of Human Cytomegalovirus DNA Polymerase Processivity Factor UL44 Attenuates Viral DNA Replication. Front. Microbiol. 2021, 12: 652719.
[4] Chuankai Sun, Yizhen Guo, Wei Zhou, Chuan Xia, Xiwen Xing, Jun Chen, Xin Li, Hua Zhu, Jie Lu*. p300 promotes cell proliferation through suppressing Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation in the infected B-lymphoma cells. Virus Res. 2020, 286: 198066.
[5] Chuan Xia#*, Jennifer J Wolf#, Chuankai Sun, Mengqiong Xu, Caleb J Studstill, Jun Chen, Hanh Ngo, Hua Zhu, Bumsuk Hahm*. PARP1 Enhances Influenza A Virus Propagation by Facilitating Degradation of Host Type I Interferon Receptor. J Virol. 2020, 94: e01572-19.
[6] Qiudi Deng, Yujun Liu, Xin Li, Bin Yan, Xu Sun, Wei Tang, Phong Trang, Zhu Yang, Hao Gong, Yu Wang, Jie Lu, Jun Chen, Chuan Xia, Xiwen Xing*, Sangwei Lu* and Fenyong Liu*. Inhibition of human cytomegalovirus major capsid protein expression and replication by ribonuclease P-associated external guide sequences. RNA. 2019, 25(5): 645-655.
[7] Sisi Xia, Jun Chen, Liqiong Liu, Yue Wei, Zixin Deng, Lianrong Wang, Shi Chen*. Tight control of genomic phosphorothioate modification by the ATP-modulated autoregulation and reusability of DndB. Molecular Microbiology. 2019, 111(4), 938–950.
[8] Yue Zhai, Peng Lin, Zhuan Feng, Huanyu Lu, Qing Han, Jun Chen, Yang Zhang, Qian He, Gang Nan, Xing Luo, Bin Wang, Fei Feng, Fenyong Liu*, Zhinan Chen* & Ping Zhu*. TNFAIP3-DEPTOR complex regulates inflammasome secretion through autophagy in ankylosing spondylitis monocytes. Autophagy. 2018, 14(9): 1629-1643.
[9] Jun Chen, Sisi Xia, Xiangmin Yang, Huizi Chen, Fanni Li, Fenyong Liu, Zhinan Chen. Human Cytomegalovirus Encoded miR-US25-1-5p Attenuates CD147/EMMPRIN-Mediated Early Antiviral Response. Viruses-Basel. 2017, 9(12): 365.
[10] Jun Luo#, Jun Chen#, Edward Yang, Ao Shen, Hao Gong, Zenglin Pei, Gengfu Xiao, Songya Lu, Fenyong Liu. Modulation of the cellular distribution of human cytomegalovirus helicase by cellular factor Snapin. J Virol. 2013, 87:10628-10640. (co-first author)
[11] Yonggang Pei, Wenmin Fu, Edward Yang, Ao Shen, Yuanchuan Chen, Hao Gong, Jun Chen, Jun Huang, Gengfu Xiao, Fenyong Liu. A Hsp40 chaperone protein interacts with and modulates the cellular distribution of the primase protein of human cytomegalovirus. PLoS pathogens. 2012, 8: e1002968.
五、专利申报
[1] 陈俊,朱桦,葛雪梅,刘小莲,一种用于抑制人巨细胞病毒感染的小核酸及其制剂与应用,2020.09,中国,暨南大学,专利申请号:CN202010978074.8。
[2]潘攀,申苗苗,陈俊,葛威威,李永奎, S63845在制备抗新冠病毒感染药物中的应用,2023.05,暨南大学附属第一医院,专利号:ZL 2022 1 1426549.8。